GlassScriptPhysician profile
Melissa D Tepe
NPI 1306928825
$10,919.83
in general payments reported to CMS, 2019-2025
8 companies · $1,625 in 2025
The $1,625 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,178 · 2020: $1,424 · 2022: $51.30 · 2023: $4,216 · 2024: $1,426 · 2025: $1,625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,021 · Food and Beverage: $161 · Long Term Medical Supply Or Device Loan: $84.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,021.00 |
| Food and Beverage | $161.14 |
| Long Term Medical Supply Or Device Loan | $84.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $7,124.48 | 2023-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $3,533.52 | 2019-2020 | |
| Baxter Healthcare | $84.47 | 2025 | Hillrom - Oae Hearing Screener |
| Hologic Sales and Service, LLC | $52.70 | 2022-2023 | Thinprep 2000 Processor, Third Wave, Aptima |
| Sanofi Pasteur INC. | $46.00 | 2020 | |
| Abbvie INC. | $40.84 | 2019-2022 | |
| Medtronic, INC. | $22.01 | 2024 | Intellis Adaptivestim |
| Optumhealth Care Solutions, LLC | $15.81 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Tepe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.